** Shares of chemicals maker Chemours CC.N up 3.1% at $17.35 premarket
** Company posts smaller Q4 loss of $8 million compared to $18 million a year ago
** Co says it has fully addressed all four material weaknesses in internal control previously identified in the 2023 Form 10-K
** CC expects consolidated net sales to be flat to slightly down sequentially in Q1
** YTD shares down 0.41% as of last close
(Reporting by Katha Kalia)
((Katha.Kalia@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.